Shanghai Jiawen Yingli Biotechnology Co., Ltd., established on 2015-05-28, Business scope includes biotechnology,Technology development in the field of medical technology,Technical Services,technology transfer,technical consulting,Chemical products and raw materials(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Sales of biological reagents for non-clinical diagnosis,Drug Wholesale,Drug retail,Medical device management,Industrial Investment,investment management,Investment Advisory. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Part of GSK Plc, GlaxoSmithKline Intellectual Property Development Ltd. is a British company located in Middlesex that functions as an investment holding company. It was founded in 2012.\nThe company says this about itself: The Company is a member of the GlaxoSmithKline Group (the \"Group\"). The Company's principal activities are the development, enhancement, maintenance, protection and exploitation of intellectual property assets owned by the Company which may include but are not limited to, licensing out intellectual property rights relating to pharmaceutical products to the GlaxoSmithKline Group of companies (the \"Group\") and carrying out research and development activities.

Shanghai Biyuntian Biotechnology Co., Ltd., established on 2007-07-19, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;pharmaceutical production;Drug Wholesale;Drug retail.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:biology,medicine,Technology research and development in the field of artificial intelligence,Technical Services,technology transfer;chemical reagent(In addition to dangerous goods),laboratory consumables,Laboratory equipment,Production and sales of Class I medical devices;Sales of Class II Medical Devices;data processing services,software development,Sales;Health Management Consulting;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Sironax Ltd. is a company headquartered in Beijing, China, that manufactures pharmaceutical products.\nThe company says this about itself: Sironax is a clinical-stage biotechnology company dedicated to the discovery and global development of novel treatments for patients with age-related degenerative diseases. Since its founding in 2017, Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways and neuroinflammation. Sironax is currently conducting early clinical studies with SIR0365 and SIR2446, in addition to ongoing preclinical research.

Zichen Marine Pharmaceutical Technology (Shanghai) Co., Ltd., established on 2017-03-07, The scope of business includes technology development in the field of marine biomedical science and technology,technology transfer,Technical Services,technical consulting,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Zhongshan Ophthalmic Center, part of Sun Yat-Sen University, is a Chinese company located in Guangzhou that operates hospitals.

Chengdu Ori Pharmaceutical Co., Ltd., established on 2020-07-03, Business scope includes licensed projects:Drug retail(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of Class I Medical Devices;Sales of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Chengdu Benokecheng Biotechnology Co., Ltd., established on 2019-02-28, The scope of business includes the research and development of biological reagents and the provision of technical consultation,technology transfer;Medical Technology Consulting(Does not include health care activities),technology transfer;Import and export of goods and technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).